20276 results for «»
20276 results
#6 - How should I prevent and manage complications when performing left main PCI?
07 Feb 2022
Watch the replay of this PCR Webinar on bifurcation with G. Stankovic, J. Fajadet, T. Lefèvre and J. Legutko.
Yu Du
Beijing, China
COMPLETE: Effects of complete revascularization on angina-related quality of life in patients with ST-segment elevation myocardial infarction
22 Mar 2022
In this interview, Mirvat Alasnag asks Shamir R. Mehta about the results of a prespecified analysis of the COMPLETE study which he presented during the ACC 2022 Scientific sessions.
Author
The FAME 3 Trial: Quality of Life After Fractional Flow Reserve-guided Stenting Compared With Coronary Bypass Surgery
03 Apr 2022
Luis Ortega-Paz interviews Frederik Zimmermann, first co-author of the FAME 3 Trial which he presented during the American College of Cardiology’s annual scientific sessions. The trial was published simultaneously in the journal Circulation.
Author
EDIT-CMD trial results: edifying our approach to patients with ANOCA
03 Apr 2022
Dejan Milasinovic provides his take on the EDIT-CMD Randomized Clinical Trial which aimed to assess the efficacy of diltiazem to improve coronary vasomotor dysfunction in angina and nonobstructive coronary arteries.
Author
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction
03 Apr 2022
Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.
Author
How should I treat? - An innovative approach to treat diffuse disease
23 Feb 2022
An 81-year-old gentleman with a history of dyslipidemia, hypertension, presenting a new onset of angina and dyspnea in the last 2 years underwent exertional test which resulted positive for ischemia.
Author
Frequency and outcomes of periprocedural MI in patients with chronic coronary syndromes undergoing PCI
09 Feb 2022
This study evaluated the frequency and impact of periprocedural MI by using various MI definitions among patients with chronic coronary syndrome (CCS) undergoing percutaneous coronary intervention (PCI).
Reviewer
Residual Leaks Post Left Atrial Appendage Occlusion
03 Apr 2022
Michele Pighi provides his take on the National Cardiovascular LAAO Registry that analyzed data from 51,333 patients who underwent LAAO procedures with the WATCHMAN device between 2016-2019, as part of the College's NCDR registries.
Author
Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial
14 Feb 2022
The purpose of the prespecified subanalysis of the EXCEL (Evaluation of XIENCE versus Coronary artery bypass surgery for Effectiveness of Left main revascularization) trial was to determine whether the outcomes remained consistent regardless of geography.
Reviewer
Reviewer
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
Mitral valve disease: diagnosis and treatment selection
23 Nov 2021 – From PCR London Valves 2021
In the first part of this PCR London Valves 2021 session, review the quantification of mitral regurgitation and learn how to better approach patients. Then, in the second part, study patient selection for specific types of procedures.
Transcatheter mitral valve implantation
22 Nov 2021 – From PCR London Valves 2021
Shot in the simulation lab at the PCR London Valves 2021 Congress, this session enables you to see some of the anatomical specimens and devices currently used for transcatheter mitral valve replacement and witness a Tendyne implantation from start to finish using a simulated heart.
How to deal with residual or recurrent mitral regurgitation after failed surgical or transcatheter repair
28 Nov 2022 – From PCR London Valves 2022
Consul this session to learn more about the available treatment options after failed mitral surgical or transcatheter procedures, the factors that increase the likelihood of residual/recurrent mitral regurgitation, and more!
Challenging scenarios during transcatheter tricuspid valve intervention
28 Nov 2022 – From PCR London Valves 2022
Consult these presentations to get insights into how the reduction of tricuspid valve coaptation gaps can facilitate tricuspid transcatheter edge-to-edge repair, to learn some tips and tricks for improved transoesophageal imaging during tricuspid valve interventions and to master techniques for the management of single leaflet device attachment during this...
Innovations in transcatheter tricuspid valve intervention - LIVE case
28 Nov 2022 – From PCR London Valves 2022
Watch two very innovative tricuspid cases you've never seen before:
- Part 1: TR replacement
An 82-year-old male with chronic atrial fibrillation and completely PM dependent for 27 years, presents a symptomatic torrential TR and an enlarged annulus with a great gap. The operators implanted for the first time in...
Challenging scenarios: bioprosthetic valve dysfunction
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the different causes of bioprosthetic valve dysfunction and the best options (surgical, transcatheter or medical) for the management of patients with this kind of dysfunction, as well as to discover how valve design impacts on durability and what the future holds...
Optimal management of right ventricular pacing leads in patients with tricuspid regurgitation
28 Nov 2022 – From PCR London Valves 2022
Consult these presentations to learn more about the consequences of right ventricular pacing lead implantation on tricuspid valve function, the diagnosis and imaging assessment of lead-induced tricuspid regurgitation and the possible treatment options for patients with right ventricular pacing leads and significant tricuspid regurgitation.
Transcatheter mitral valve interventions: clinical outcomes 2
28 Nov 2022 – From PCR London Valves 2022
This PCR LV 2022 session will enable you to discover outcomes of transcatheter edge-to-edge MVR in patients with right ventricle dysfunction, TEER for MR early after myocardial infarction, or a predictive selection of patients for TMVR, among others!
TAVI: technical considerations
28 Nov 2022 – From PCR London Valves 2022
Consult this session on TAVI technical considerations to discover a selection of cases presented during PCR LV 2022: transseptal snaring as a bailout from valvuloplasty balloon entrapment within a self-expanding valve, severe thrombocytopenia and severe aortic stenosis, embolisation of a fully deployed Evolute valve due to chest...
